Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murty V Chengalvala

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
GnRH agonists and antagonists in cancer therapyMurty V Chengalvala, Jeffrey C Pelletier, Gregory S Kopf
Current Genomics|July 23, 2008
Gene expression profiling and its practice in drug developmentMurty V Chengalvala, Vargheese M Chennathukuzhi, Daniel S Johnston, et al.
Current Pharmaceutical Design|November 1, 2006
Regulation of female fertility and identification of future contraceptive targetsMurty V Chengalvala, Edwin H Meade, Joshua E Cottom, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2010
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptorMatthew D Vera, Joseph T Lundquist, Murty V Chengalvala, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole templateDiane B Hauze, Murty V Chengalvala, Joshua E Cottom, et al.
Journal of Medicinal Chemistry|March 11, 2009
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)Jeffrey C Pelletier, Murty V Chengalvala, Joshua E Cottom, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
GnRH agonists and antagonists in cancer therapyMurty V Chengalvala, Jeffrey C Pelletier, Gregory S Kopf
Current Genomics|July 23, 2008
Gene expression profiling and its practice in drug developmentMurty V Chengalvala, Vargheese M Chennathukuzhi, Daniel S Johnston, et al.
Current Pharmaceutical Design|November 1, 2006
Regulation of female fertility and identification of future contraceptive targetsMurty V Chengalvala, Edwin H Meade, Joshua E Cottom, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2010
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptorMatthew D Vera, Joseph T Lundquist, Murty V Chengalvala, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole templateDiane B Hauze, Murty V Chengalvala, Joshua E Cottom, et al.
Journal of Medicinal Chemistry|March 11, 2009
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)Jeffrey C Pelletier, Murty V Chengalvala, Joshua E Cottom, et al.
Pageof 1